nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—Hypertensive—Octreotide—thymus cancer	0.0859	0.122	CcSEcCtD
Perindopril—BCHE—diaphragm—thymus cancer	0.0576	0.196	CbGeAlD
Perindopril—ACE—pulmonary artery—thymus cancer	0.053	0.18	CbGeAlD
Perindopril—ACE—vein—thymus cancer	0.0482	0.164	CbGeAlD
Perindopril—Ear infection—Octreotide—thymus cancer	0.0233	0.033	CcSEcCtD
Perindopril—Stomach ache—Octreotide—thymus cancer	0.0233	0.033	CcSEcCtD
Perindopril—Pancreatitis acute—Octreotide—thymus cancer	0.0215	0.0304	CcSEcCtD
Perindopril—Haematoma—Octreotide—thymus cancer	0.0158	0.0223	CcSEcCtD
Perindopril—Menstrual disorder—Octreotide—thymus cancer	0.0145	0.0206	CcSEcCtD
Perindopril—Nephrolithiasis—Octreotide—thymus cancer	0.0123	0.0174	CcSEcCtD
Perindopril—Viral infection—Octreotide—thymus cancer	0.011	0.0155	CcSEcCtD
Perindopril—ACE—neck—thymus cancer	0.0109	0.0373	CbGeAlD
Perindopril—Drug interaction—Octreotide—thymus cancer	0.0107	0.0151	CcSEcCtD
Perindopril—SLC15A1—epithelium—thymus cancer	0.0104	0.0354	CbGeAlD
Perindopril—Vaginal inflammation—Octreotide—thymus cancer	0.00991	0.014	CcSEcCtD
Perindopril—Hyperkalaemia—Octreotide—thymus cancer	0.00973	0.0138	CcSEcCtD
Perindopril—Vaginal infection—Octreotide—thymus cancer	0.00935	0.0132	CcSEcCtD
Perindopril—Urine output increased—Octreotide—thymus cancer	0.00896	0.0127	CcSEcCtD
Perindopril—Hyperkinesia—Octreotide—thymus cancer	0.00864	0.0122	CcSEcCtD
Perindopril—Sleep disorder—Octreotide—thymus cancer	0.00831	0.0118	CcSEcCtD
Perindopril—Polyuria—Octreotide—thymus cancer	0.00819	0.0116	CcSEcCtD
Perindopril—ACE—hematopoietic system—thymus cancer	0.00815	0.0277	CbGeAlD
Perindopril—Gastroenteritis—Octreotide—thymus cancer	0.00811	0.0115	CcSEcCtD
Perindopril—Hot flush—Octreotide—thymus cancer	0.00769	0.0109	CcSEcCtD
Perindopril—Amnesia—Octreotide—thymus cancer	0.00765	0.0108	CcSEcCtD
Perindopril—Menopausal symptoms—Octreotide—thymus cancer	0.00762	0.0108	CcSEcCtD
Perindopril—ACE—epithelium—thymus cancer	0.00745	0.0254	CbGeAlD
Perindopril—Anaphylactoid reaction—Octreotide—thymus cancer	0.00743	0.0105	CcSEcCtD
Perindopril—Arthritis—Octreotide—thymus cancer	0.0074	0.0105	CcSEcCtD
Perindopril—Pain in extremity—Octreotide—thymus cancer	0.00719	0.0102	CcSEcCtD
Perindopril—Dry skin—Octreotide—thymus cancer	0.00659	0.00933	CcSEcCtD
Perindopril—Abdominal pain upper—Octreotide—thymus cancer	0.00657	0.0093	CcSEcCtD
Perindopril—Cramp muscle—Octreotide—thymus cancer	0.00647	0.00917	CcSEcCtD
Perindopril—Nasopharyngitis—Octreotide—thymus cancer	0.00643	0.0091	CcSEcCtD
Perindopril—Muscular weakness—Octreotide—thymus cancer	0.00634	0.00898	CcSEcCtD
Perindopril—Asthma—Octreotide—thymus cancer	0.00621	0.0088	CcSEcCtD
Perindopril—ACE—cardiac atrium—thymus cancer	0.00619	0.0211	CbGeAlD
Perindopril—Bronchospasm—Octreotide—thymus cancer	0.00611	0.00865	CcSEcCtD
Perindopril—Pancreatitis—Octreotide—thymus cancer	0.00609	0.00863	CcSEcCtD
Perindopril—ACE—pituitary gland—thymus cancer	0.00604	0.0206	CbGeAlD
Perindopril—BCHE—hematopoietic system—thymus cancer	0.00602	0.0205	CbGeAlD
Perindopril—Bronchitis—Octreotide—thymus cancer	0.00598	0.00846	CcSEcCtD
Perindopril—Upper respiratory tract infection—Octreotide—thymus cancer	0.00578	0.00818	CcSEcCtD
Perindopril—Pollakiuria—Octreotide—thymus cancer	0.00574	0.00813	CcSEcCtD
Perindopril—ACE—lymphoid tissue—thymus cancer	0.00574	0.0195	CbGeAlD
Perindopril—Pneumonia—Octreotide—thymus cancer	0.00557	0.00789	CcSEcCtD
Perindopril—Drowsiness—Octreotide—thymus cancer	0.00554	0.00784	CcSEcCtD
Perindopril—Jaundice—Octreotide—thymus cancer	0.0054	0.00765	CcSEcCtD
Perindopril—Urinary tract infection—Octreotide—thymus cancer	0.00539	0.00762	CcSEcCtD
Perindopril—Conjunctivitis—Octreotide—thymus cancer	0.00539	0.00762	CcSEcCtD
Perindopril—Haematuria—Octreotide—thymus cancer	0.00528	0.00748	CcSEcCtD
Perindopril—SLC15A2—pituitary gland—thymus cancer	0.00527	0.0179	CbGeAlD
Perindopril—Hepatobiliary disease—Octreotide—thymus cancer	0.00524	0.00742	CcSEcCtD
Perindopril—Epistaxis—Octreotide—thymus cancer	0.00523	0.0074	CcSEcCtD
Perindopril—ACE—bone marrow—thymus cancer	0.00522	0.0178	CbGeAlD
Perindopril—ACE—thyroid gland—thymus cancer	0.00521	0.0177	CbGeAlD
Perindopril—Sinusitis—Octreotide—thymus cancer	0.0052	0.00736	CcSEcCtD
Perindopril—Bradycardia—Octreotide—thymus cancer	0.00506	0.00717	CcSEcCtD
Perindopril—Rhinitis—Octreotide—thymus cancer	0.00499	0.00706	CcSEcCtD
Perindopril—Hepatitis—Octreotide—thymus cancer	0.00497	0.00704	CcSEcCtD
Perindopril—Pharyngitis—Octreotide—thymus cancer	0.00494	0.00699	CcSEcCtD
Perindopril—Oedema peripheral—Octreotide—thymus cancer	0.0049	0.00694	CcSEcCtD
Perindopril—Visual impairment—Octreotide—thymus cancer	0.00479	0.00679	CcSEcCtD
Perindopril—ACE—lung—thymus cancer	0.00473	0.0161	CbGeAlD
Perindopril—Tinnitus—Octreotide—thymus cancer	0.00464	0.00657	CcSEcCtD
Perindopril—Cardiac disorder—Octreotide—thymus cancer	0.00462	0.00654	CcSEcCtD
Perindopril—Flushing—Octreotide—thymus cancer	0.00462	0.00654	CcSEcCtD
Perindopril—BCHE—cardiac atrium—thymus cancer	0.00457	0.0156	CbGeAlD
Perindopril—SLC15A2—thyroid gland—thymus cancer	0.00454	0.0155	CbGeAlD
Perindopril—BCHE—pituitary gland—thymus cancer	0.00446	0.0152	CbGeAlD
Perindopril—Arrhythmia—Octreotide—thymus cancer	0.00444	0.00629	CcSEcCtD
Perindopril—Alopecia—Octreotide—thymus cancer	0.0044	0.00622	CcSEcCtD
Perindopril—Mental disorder—Octreotide—thymus cancer	0.00436	0.00617	CcSEcCtD
Perindopril—Erythema—Octreotide—thymus cancer	0.00433	0.00613	CcSEcCtD
Perindopril—Malnutrition—Octreotide—thymus cancer	0.00433	0.00613	CcSEcCtD
Perindopril—Flatulence—Octreotide—thymus cancer	0.00427	0.00604	CcSEcCtD
Perindopril—Tension—Octreotide—thymus cancer	0.00425	0.00602	CcSEcCtD
Perindopril—Nervousness—Octreotide—thymus cancer	0.00421	0.00595	CcSEcCtD
Perindopril—Back pain—Octreotide—thymus cancer	0.00419	0.00593	CcSEcCtD
Perindopril—Muscle spasms—Octreotide—thymus cancer	0.00416	0.00589	CcSEcCtD
Perindopril—SLC15A2—lung—thymus cancer	0.00413	0.0141	CbGeAlD
Perindopril—Tremor—Octreotide—thymus cancer	0.00406	0.00574	CcSEcCtD
Perindopril—Ill-defined disorder—Octreotide—thymus cancer	0.00402	0.00569	CcSEcCtD
Perindopril—Anaemia—Octreotide—thymus cancer	0.004	0.00567	CcSEcCtD
Perindopril—Agitation—Octreotide—thymus cancer	0.00398	0.00563	CcSEcCtD
Perindopril—Malaise—Octreotide—thymus cancer	0.0039	0.00553	CcSEcCtD
Perindopril—Vertigo—Octreotide—thymus cancer	0.00389	0.00551	CcSEcCtD
Perindopril—Syncope—Octreotide—thymus cancer	0.00388	0.0055	CcSEcCtD
Perindopril—BCHE—bone marrow—thymus cancer	0.00386	0.0131	CbGeAlD
Perindopril—BCHE—thyroid gland—thymus cancer	0.00385	0.0131	CbGeAlD
Perindopril—Palpitations—Octreotide—thymus cancer	0.00383	0.00542	CcSEcCtD
Perindopril—Loss of consciousness—Octreotide—thymus cancer	0.00381	0.00539	CcSEcCtD
Perindopril—Cough—Octreotide—thymus cancer	0.00378	0.00535	CcSEcCtD
Perindopril—Hypertension—Octreotide—thymus cancer	0.00374	0.00529	CcSEcCtD
Perindopril—Chest pain—Octreotide—thymus cancer	0.00369	0.00522	CcSEcCtD
Perindopril—Myalgia—Octreotide—thymus cancer	0.00369	0.00522	CcSEcCtD
Perindopril—Arthralgia—Octreotide—thymus cancer	0.00369	0.00522	CcSEcCtD
Perindopril—Anxiety—Octreotide—thymus cancer	0.00367	0.0052	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00366	0.00518	CcSEcCtD
Perindopril—Discomfort—Octreotide—thymus cancer	0.00364	0.00516	CcSEcCtD
Perindopril—Dry mouth—Octreotide—thymus cancer	0.00361	0.0051	CcSEcCtD
Perindopril—Oedema—Octreotide—thymus cancer	0.00353	0.005	CcSEcCtD
Perindopril—Anaphylactic shock—Octreotide—thymus cancer	0.00353	0.005	CcSEcCtD
Perindopril—BCHE—lung—thymus cancer	0.00349	0.0119	CbGeAlD
Perindopril—Shock—Octreotide—thymus cancer	0.00348	0.00492	CcSEcCtD
Perindopril—Nervous system disorder—Octreotide—thymus cancer	0.00347	0.00491	CcSEcCtD
Perindopril—Thrombocytopenia—Octreotide—thymus cancer	0.00346	0.0049	CcSEcCtD
Perindopril—Tachycardia—Octreotide—thymus cancer	0.00345	0.00488	CcSEcCtD
Perindopril—Skin disorder—Octreotide—thymus cancer	0.00343	0.00486	CcSEcCtD
Perindopril—Hyperhidrosis—Octreotide—thymus cancer	0.00342	0.00484	CcSEcCtD
Perindopril—Anorexia—Octreotide—thymus cancer	0.00337	0.00477	CcSEcCtD
Perindopril—ACE—lymph node—thymus cancer	0.00324	0.011	CbGeAlD
Perindopril—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00322	0.00456	CcSEcCtD
Perindopril—Insomnia—Octreotide—thymus cancer	0.0032	0.00452	CcSEcCtD
Perindopril—Paraesthesia—Octreotide—thymus cancer	0.00317	0.00449	CcSEcCtD
Perindopril—Dyspnoea—Octreotide—thymus cancer	0.00315	0.00446	CcSEcCtD
Perindopril—Somnolence—Octreotide—thymus cancer	0.00314	0.00445	CcSEcCtD
Perindopril—Dyspepsia—Octreotide—thymus cancer	0.00311	0.0044	CcSEcCtD
Perindopril—Decreased appetite—Octreotide—thymus cancer	0.00307	0.00435	CcSEcCtD
Perindopril—Gastrointestinal disorder—Octreotide—thymus cancer	0.00305	0.00432	CcSEcCtD
Perindopril—Fatigue—Octreotide—thymus cancer	0.00305	0.00431	CcSEcCtD
Perindopril—Pain—Octreotide—thymus cancer	0.00302	0.00428	CcSEcCtD
Perindopril—Constipation—Octreotide—thymus cancer	0.00302	0.00428	CcSEcCtD
Perindopril—Feeling abnormal—Octreotide—thymus cancer	0.00291	0.00412	CcSEcCtD
Perindopril—Gastrointestinal pain—Octreotide—thymus cancer	0.00289	0.00409	CcSEcCtD
Perindopril—ABCB1—hematopoietic system—thymus cancer	0.00287	0.00977	CbGeAlD
Perindopril—SLC15A2—lymph node—thymus cancer	0.00282	0.00961	CbGeAlD
Perindopril—Urticaria—Octreotide—thymus cancer	0.00281	0.00397	CcSEcCtD
Perindopril—Abdominal pain—Octreotide—thymus cancer	0.00279	0.00395	CcSEcCtD
Perindopril—Body temperature increased—Octreotide—thymus cancer	0.00279	0.00395	CcSEcCtD
Perindopril—ABCB1—epithelium—thymus cancer	0.00262	0.00893	CbGeAlD
Perindopril—Asthenia—Octreotide—thymus cancer	0.00254	0.00359	CcSEcCtD
Perindopril—Pruritus—Octreotide—thymus cancer	0.0025	0.00354	CcSEcCtD
Perindopril—Diarrhoea—Octreotide—thymus cancer	0.00242	0.00342	CcSEcCtD
Perindopril—BCHE—lymph node—thymus cancer	0.00239	0.00814	CbGeAlD
Perindopril—Dizziness—Octreotide—thymus cancer	0.00234	0.00331	CcSEcCtD
Perindopril—Vomiting—Octreotide—thymus cancer	0.00225	0.00318	CcSEcCtD
Perindopril—Rash—Octreotide—thymus cancer	0.00223	0.00315	CcSEcCtD
Perindopril—Dermatitis—Octreotide—thymus cancer	0.00223	0.00315	CcSEcCtD
Perindopril—Headache—Octreotide—thymus cancer	0.00221	0.00313	CcSEcCtD
Perindopril—ABCB1—pituitary gland—thymus cancer	0.00213	0.00724	CbGeAlD
Perindopril—Nausea—Octreotide—thymus cancer	0.0021	0.00297	CcSEcCtD
Perindopril—ABCB1—lymphoid tissue—thymus cancer	0.00202	0.00688	CbGeAlD
Perindopril—ABCB1—bone marrow—thymus cancer	0.00184	0.00626	CbGeAlD
Perindopril—ABCB1—thyroid gland—thymus cancer	0.00183	0.00625	CbGeAlD
Perindopril—ABCB1—lung—thymus cancer	0.00167	0.00567	CbGeAlD
Perindopril—ABCB1—lymph node—thymus cancer	0.00114	0.00388	CbGeAlD
